DR. LUCAS HELLER M.D.
Prescription History 1982970976
Internal Medicine - Endocrinology, Diabetes & Metabolism in Irwin, PA

Active since March 24, 2012PECOS EnrolledAccepts Medicare Assignment
8775 NORWIN AVE STE 100, IRWIN, PA 15642(833) 604-7211(724) 537-1066 Get Directions

NPPES record last updated: September 10, 2025. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Sep 10, 2025, Apr 9, 2019 (2 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. LUCAS HELLER M.D., an active Endocrinology, Diabetes & Metabolism specialist practicing in Irwin, PA. Our medical registry currently tracks 64 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,925 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 538 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

64
Medications
3,925
Total Claims
9,012
30-Day Fills
Levothyroxine Sodium
Most Prescribed · 538 claims
View details
64 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by DR. LUCAS HELLER M.D. in 2024, with prescription volumes, average cost per fill, and PA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other PA PrescribersVs. PA Avg

About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2024, this provider wrote 538 Medicare prescriptions for Levothyroxine Sodium, about 3.1 times the volume of the typical Pennsylvania prescriber of this medication (174.6). Medicare paid an average of $12.50 per fill, versus $10.98 statewide.

How often this provider prescribes it

This provider
538
PA average
174.6

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12.50
PA average
$10.98

Gross Part D cost per fill; not the patient's out-of-pocket price.

1,476.6
30-Day Fills
standardized to 30-day supplies
44,194
Days of Medication
total across all patients in 2024

About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT.

In 2024, this provider wrote 369 Medicare prescriptions for Ozempic, about 6.1 times the volume of the typical Pennsylvania prescriber of this medication (61). Medicare paid an average of $1,511.01 per fill, versus $1,230.71 statewide.

How often this provider prescribes it

This provider
369
PA average
61.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,511.01
PA average
$1,230.71

Gross Part D cost per fill; not the patient's out-of-pocket price.

604.1
30-Day Fills
standardized to 30-day supplies
17,678
Days of Medication
total across all patients in 2024

About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure and kidney disease. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure or kidney disease. It also helps to lower the risk of dialysis in people with kidney disease. Empagliflozin works by increasing the removal of sodium by your kidneys.

In 2024, this provider wrote 246 Medicare prescriptions for Jardiance, about 4 times the volume of the typical Pennsylvania prescriber of this medication (60.8). Medicare paid an average of $1,206.37 per fill, versus $952.57 statewide.

How often this provider prescribes it

This provider
246
PA average
60.8

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,206.37
PA average
$952.57

Gross Part D cost per fill; not the patient's out-of-pocket price.

521.3
30-Day Fills
standardized to 30-day supplies
15,616
Days of Medication
total across all patients in 2024

About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. A glucagon-like peptide-1 receptor agonist; GLP-1 immunoglobulin G (IgG4) Fc fusion protein with extended activity.

In 2024, this provider wrote 192 Medicare prescriptions for Trulicity, about 4.3 times the volume of the typical Pennsylvania prescriber of this medication (44.4). Medicare paid an average of $1,324.83 per fill, versus $1,180.94 statewide.

How often this provider prescribes it

This provider
192
PA average
44.4

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,324.83
PA average
$1,180.94

Gross Part D cost per fill; not the patient's out-of-pocket price.

263.3
30-Day Fills
standardized to 30-day supplies
7,594
Days of Medication
total across all patients in 2024

About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾

It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

In 2024, this provider wrote 160 Medicare prescriptions for Metformin Hcl Er, about 2.7 times the volume of the typical Pennsylvania prescriber of this medication (59.3). Medicare paid an average of $15.34 per fill, versus $13.68 statewide.

How often this provider prescribes it

This provider
160
PA average
59.3

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.34
PA average
$13.68

Gross Part D cost per fill; not the patient's out-of-pocket price.

410.7
30-Day Fills
standardized to 30-day supplies
12,301
Days of Medication
total across all patients in 2024

About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2024, this provider wrote 155 Medicare prescriptions for Synthroid, about 3.3 times the volume of the typical Pennsylvania prescriber of this medication (46.5). Medicare paid an average of $66.28 per fill, versus $61.27 statewide.

How often this provider prescribes it

This provider
155
PA average
46.5

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$66.28
PA average
$61.27

Gross Part D cost per fill; not the patient's out-of-pocket price.

381.7
30-Day Fills
standardized to 30-day supplies
11,412
Days of Medication
total across all patients in 2024

About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾

It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

In 2024, this provider wrote 151 Medicare prescriptions for Metformin Hcl, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (103.2). Medicare paid an average of $8.56 per fill, versus $8.60 statewide.

How often this provider prescribes it

This provider
151
PA average
103.2

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$8.56
PA average
$8.60

This provider's average cost per fill is below the PA average for this medication.

412.8
30-Day Fills
standardized to 30-day supplies
12,385
Days of Medication
total across all patients in 2024

About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

In 2024, this provider wrote 139 Medicare prescriptions for Toujeo Solostar, about 5.3 times the volume of the typical Pennsylvania prescriber of this medication (26.1). Medicare paid an average of $733.04 per fill, versus $681.03 statewide.

How often this provider prescribes it

This provider
139
PA average
26.1

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$733.04
PA average
$681.03

Gross Part D cost per fill; not the patient's out-of-pocket price.

318.5
30-Day Fills
standardized to 30-day supplies
9,462
Days of Medication
total across all patients in 2024

About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

In 2024, this provider wrote 134 Medicare prescriptions for Lantus Solostar, about 2.8 times the volume of the typical Pennsylvania prescriber of this medication (47.5). Medicare paid an average of $145.88 per fill, versus $113.34 statewide.

How often this provider prescribes it

This provider
134
PA average
47.5

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$145.88
PA average
$113.34

Gross Part D cost per fill; not the patient's out-of-pocket price.

325.1
30-Day Fills
standardized to 30-day supplies
9,710
Days of Medication
total across all patients in 2024

About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS.

In 2024, this provider wrote 130 Medicare prescriptions for Mounjaro, about 3 times the volume of the typical Pennsylvania prescriber of this medication (43.7). Medicare paid an average of $1,441.64 per fill, versus $1,230.18 statewide.

How often this provider prescribes it

This provider
130
PA average
43.7

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,441.64
PA average
$1,230.18

Gross Part D cost per fill; not the patient's out-of-pocket price.

180.6
30-Day Fills
standardized to 30-day supplies
5,221
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 124 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 3.6 times the volume of the typical Pennsylvania prescriber of this medication (34.5). Medicare paid an average of $121.17 per fill, versus $92.24 statewide.

How often this provider prescribes it

This provider
124
PA average
34.5

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$121.17
PA average
$92.24

Gross Part D cost per fill; not the patient's out-of-pocket price.

315.8
30-Day Fills
standardized to 30-day supplies
9,419
Days of Medication
total across all patients in 2024

About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

In 2024, this provider wrote 100 Medicare prescriptions for Glimepiride, about 2.3 times the volume of the typical Pennsylvania prescriber of this medication (42.9). Medicare paid an average of $15.94 per fill, versus $11.29 statewide.

How often this provider prescribes it

This provider
100
PA average
42.9

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.94
PA average
$11.29

Gross Part D cost per fill; not the patient's out-of-pocket price.

299.5
30-Day Fills
standardized to 30-day supplies
8,985
Days of Medication
total across all patients in 2024

About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2024, this provider wrote 89 Medicare prescriptions for Humalog Kwikpen U-100, about 2.6 times the volume of the typical Pennsylvania prescriber of this medication (34.8). Medicare paid an average of $278.66 per fill, versus $235.82 statewide.

How often this provider prescribes it

This provider
89
PA average
34.8

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$278.66
PA average
$235.82

Gross Part D cost per fill; not the patient's out-of-pocket price.

193.9
30-Day Fills
standardized to 30-day supplies
5,727
Days of Medication
total across all patients in 2024

About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾

It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.

In 2024, this provider wrote 77 Medicare prescriptions for Rosuvastatin Calcium, about 62% of the volume of the typical Pennsylvania prescriber of this medication (124.4). Medicare paid an average of $13.81 per fill, versus $16.32 statewide.

How often this provider prescribes it

This provider
77
PA average
124.4

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$13.81
PA average
$16.32

This provider's average cost per fill is below the PA average for this medication.

227.7
30-Day Fills
standardized to 30-day supplies
6,831
Days of Medication
total across all patients in 2024

About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾

Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

In 2024, this provider wrote 75 Medicare prescriptions for Alendronate Sodium, about 1.6 times the volume of the typical Pennsylvania prescriber of this medication (47.7). Medicare paid an average of $4.16 per fill, versus $9.39 statewide.

How often this provider prescribes it

This provider
75
PA average
47.7

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$4.16
PA average
$9.39

This provider's average cost per fill is below the PA average for this medication.

144.6
30-Day Fills
standardized to 30-day supplies
4,265
Days of Medication
total across all patients in 2024

About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾

It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.

In 2024, this provider wrote 73 Medicare prescriptions for Methimazole, about 2 times the volume of the typical Pennsylvania prescriber of this medication (37.1). Medicare paid an average of $14.28 per fill, versus $10.95 statewide.

How often this provider prescribes it

This provider
73
PA average
37.1

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$14.28
PA average
$10.95

Gross Part D cost per fill; not the patient's out-of-pocket price.

179.2
30-Day Fills
standardized to 30-day supplies
5,376
Days of Medication
total across all patients in 2024

About Prolia: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾

Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.

In 2024, this provider wrote 72 Medicare prescriptions for Prolia, about 2.7 times the volume of the typical Pennsylvania prescriber of this medication (26.7). Medicare paid an average of $1,733.68 per fill, versus $1,700.78 statewide.

How often this provider prescribes it

This provider
72
PA average
26.7

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,733.68
PA average
$1,700.78

Gross Part D cost per fill; not the patient's out-of-pocket price.

423
30-Day Fills
standardized to 30-day supplies
12,690
Days of Medication
total across all patients in 2024

About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

In 2024, this provider wrote 62 Medicare prescriptions for Tresiba Flextouch U-100, about 2 times the volume of the typical Pennsylvania prescriber of this medication (31.7). Medicare paid an average of $780.45 per fill, versus $646.06 statewide.

How often this provider prescribes it

This provider
62
PA average
31.7

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$780.45
PA average
$646.06

Gross Part D cost per fill; not the patient's out-of-pocket price.

172.4
30-Day Fills
standardized to 30-day supplies
5,164
Days of Medication
total across all patients in 2024

About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾

It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

In 2024, this provider wrote 56 Medicare prescriptions for Gabapentin, about half the volume of the typical Pennsylvania prescriber of this medication (100.2). Medicare paid an average of $22.38 per fill, versus $14.77 statewide.

How often this provider prescribes it

This provider
56
PA average
100.2

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$22.38
PA average
$14.77

Gross Part D cost per fill; not the patient's out-of-pocket price.

107.3
30-Day Fills
standardized to 30-day supplies
3,220
Days of Medication
total across all patients in 2024

About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾

Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

In 2024, this provider wrote 54 Medicare prescriptions for Hydrocortisone, about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (30.5). Medicare paid an average of $48.46 per fill, versus $18.27 statewide.

How often this provider prescribes it

This provider
54
PA average
30.5

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$48.46
PA average
$18.27

Gross Part D cost per fill; not the patient's out-of-pocket price.

99.2
30-Day Fills
standardized to 30-day supplies
2,975
Days of Medication
total across all patients in 2024

About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2024, this provider wrote 50 Medicare prescriptions for Humalog, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (26.9). Medicare paid an average of $202.99 per fill, versus $191.36 statewide.

How often this provider prescribes it

This provider
50
PA average
26.9

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$202.99
PA average
$191.36

Gross Part D cost per fill; not the patient's out-of-pocket price.

79.2
30-Day Fills
standardized to 30-day supplies
2,338
Days of Medication
total across all patients in 2024

About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

In 2024, this provider wrote 47 Medicare prescriptions for Tresiba Flextouch U-200, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (30.5). Medicare paid an average of $1,382.28 per fill, versus $1,104.89 statewide.

How often this provider prescribes it

This provider
47
PA average
30.5

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,382.28
PA average
$1,104.89

Gross Part D cost per fill; not the patient's out-of-pocket price.

139.5
30-Day Fills
standardized to 30-day supplies
4,184
Days of Medication
total across all patients in 2024

About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It helps to lower the risk of death from heart disease and reduces the need of going to a doctor or hospital to treat heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys.

In 2024, this provider wrote 46 Medicare prescriptions for Farxiga, about the same volume as the typical Pennsylvania prescriber of this medication (40.7). Medicare paid an average of $850.64 per fill, versus $877.86 statewide.

How often this provider prescribes it

This provider
46
PA average
40.7

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$850.64
PA average
$877.86

This provider's average cost per fill is below the PA average for this medication.

70
30-Day Fills
standardized to 30-day supplies
2,100
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 38 Medicare prescriptions for Omnipod 5 Dexg7g6 Pods (Gen 5), about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (31.9). Medicare paid an average of $1,097.39 per fill, versus $1,102.53 statewide.

How often this provider prescribes it

This provider
38
PA average
31.9

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,097.39
PA average
$1,102.53

This provider's average cost per fill is below the PA average for this medication.

64
30-Day Fills
standardized to 30-day supplies
1,920
Days of Medication
total across all patients in 2024

About Unithroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2024, this provider wrote 37 Medicare prescriptions for Unithroid, about 77% of the volume of the typical Pennsylvania prescriber of this medication (48.1). Medicare paid an average of $49.77 per fill, versus $21.85 statewide.

How often this provider prescribes it

This provider
37
PA average
48.1

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$49.77
PA average
$21.85

Gross Part D cost per fill; not the patient's out-of-pocket price.

103.5
30-Day Fills
standardized to 30-day supplies
3,106
Days of Medication
total across all patients in 2024

About Repaglinide: Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾

It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet.

In 2024, this provider wrote 37 Medicare prescriptions for Repaglinide, about the same volume as the typical Pennsylvania prescriber of this medication (32.9). Medicare paid an average of $29.20 per fill, versus $37.24 statewide.

How often this provider prescribes it

This provider
37
PA average
32.9

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$29.20
PA average
$37.24

This provider's average cost per fill is below the PA average for this medication.

95
30-Day Fills
standardized to 30-day supplies
2,850
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 36 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 1.6 times the volume of the typical Pennsylvania prescriber of this medication (23.2). Medicare paid an average of $100.25 per fill, versus $83.55 statewide.

How often this provider prescribes it

This provider
36
PA average
23.2

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$100.25
PA average
$83.55

Gross Part D cost per fill; not the patient's out-of-pocket price.

95.3
30-Day Fills
standardized to 30-day supplies
2,860
Days of Medication
total across all patients in 2024

About Glipizide Er: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

In 2024, this provider wrote 36 Medicare prescriptions for Glipizide Er, about the same volume as the typical Pennsylvania prescriber of this medication (36.1). Medicare paid an average of $20.95 per fill, versus $16.80 statewide.

How often this provider prescribes it

This provider
36
PA average
36.1

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$20.95
PA average
$16.80

Gross Part D cost per fill; not the patient's out-of-pocket price.

100
30-Day Fills
standardized to 30-day supplies
3,000
Days of Medication
total across all patients in 2024

About Testosterone Cypionate: This medication is used in men who do not make enough of a natural substance called testosterone. Show more ▾

In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. Some brands may also be used to treat certain types of breast cancer in women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.

In 2024, this provider wrote 32 Medicare prescriptions for Testosterone Cypionate, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (22). Medicare paid an average of $57.78 per fill, versus $31.76 statewide.

How often this provider prescribes it

This provider
32
PA average
22.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$57.78
PA average
$31.76

Gross Part D cost per fill; not the patient's out-of-pocket price.

46.6
30-Day Fills
standardized to 30-day supplies
1,365
Days of Medication
total across all patients in 2024

About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

In 2024, this provider wrote 24 Medicare prescriptions for Novolog Flexpen, about 68% of the volume of the typical Pennsylvania prescriber of this medication (35.2). Medicare paid an average of $262.32 per fill, versus $227.65 statewide.

How often this provider prescribes it

This provider
24
PA average
35.2

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$262.32
PA average
$227.65

Gross Part D cost per fill; not the patient's out-of-pocket price.

58.2
30-Day Fills
standardized to 30-day supplies
1,747
Days of Medication
total across all patients in 2024

About Toujeo Max Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

In 2024, this provider wrote 24 Medicare prescriptions for Toujeo Max Solostar, about 86% of the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $1,651.53 per fill, versus $1,070.16 statewide.

How often this provider prescribes it

This provider
24
PA average
28.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,651.53
PA average
$1,070.16

Gross Part D cost per fill; not the patient's out-of-pocket price.

65.5
30-Day Fills
standardized to 30-day supplies
1,966
Days of Medication
total across all patients in 2024

About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾

Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

In 2024, this provider wrote 24 Medicare prescriptions for Prednisone, about half the volume of the typical Pennsylvania prescriber of this medication (49.6). Medicare paid an average of $6.47 per fill, versus $4.09 statewide.

How often this provider prescribes it

This provider
24
PA average
49.6

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.47
PA average
$4.09

Gross Part D cost per fill; not the patient's out-of-pocket price.

40.2
30-Day Fills
standardized to 30-day supplies
1,181
Days of Medication
total across all patients in 2024

About Raloxifene Hcl: Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. Show more ▾

It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. This medication should not be used before menopause. It should not be used to prevent heart disease. A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.

In 2024, this provider wrote 23 Medicare prescriptions for Raloxifene Hcl, about the same volume as the typical Pennsylvania prescriber of this medication (22.5). Medicare paid an average of $64.21 per fill, versus $46.67 statewide.

How often this provider prescribes it

This provider
23
PA average
22.5

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$64.21
PA average
$46.67

Gross Part D cost per fill; not the patient's out-of-pocket price.

57
30-Day Fills
standardized to 30-day supplies
1,710
Days of Medication
total across all patients in 2024

About Insulin Aspart Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

In 2024, this provider wrote 23 Medicare prescriptions for Insulin Aspart Flexpen, about the same volume as the typical Pennsylvania prescriber of this medication (22.7). Medicare paid an average of $328.28 per fill, versus $156.39 statewide.

How often this provider prescribes it

This provider
23
PA average
22.7

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$328.28
PA average
$156.39

Gross Part D cost per fill; not the patient's out-of-pocket price.

51
30-Day Fills
standardized to 30-day supplies
1,506
Days of Medication
total across all patients in 2024

About Euthyrox: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2024, this provider wrote 21 Medicare prescriptions for Euthyrox, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (16.9). Medicare paid an average of $6.94 per fill, versus $7.99 statewide.

How often this provider prescribes it

This provider
21
PA average
16.9

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.94
PA average
$7.99

This provider's average cost per fill is below the PA average for this medication.

21
30-Day Fills
standardized to 30-day supplies
630
Days of Medication
total across all patients in 2024

About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

In 2024, this provider wrote 20 Medicare prescriptions for Lisinopril, about 15% of the volume of the typical Pennsylvania prescriber of this medication (136). Medicare paid an average of $6.01 per fill, versus $7.55 statewide.

How often this provider prescribes it

This provider
20
PA average
136.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.01
PA average
$7.55

This provider's average cost per fill is below the PA average for this medication.

36
30-Day Fills
standardized to 30-day supplies
1,080
Days of Medication
total across all patients in 2024

About Ezetimibe: Ezetimibe is used along with a low cholesterol/low fat diet and exercise to help lower cholesterol in the blood. Show more ▾

Ezetimibe may be used alone or with other drugs (such as "statins" or fibrates). Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Reducing cholesterol may help prevent strokes and heart attacks. An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS.

In 2024, this provider wrote 20 Medicare prescriptions for Ezetimibe, about a third of the volume of the typical Pennsylvania prescriber of this medication (54.7). Medicare paid an average of $11.93 per fill, versus $26.44 statewide.

How often this provider prescribes it

This provider
20
PA average
54.7

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$11.93
PA average
$26.44

This provider's average cost per fill is below the PA average for this medication.

36
30-Day Fills
standardized to 30-day supplies
1,080
Days of Medication
total across all patients in 2024

About Fenofibrate: Fenofibrate is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾

It works by increasing the natural substance (enzyme) that breaks down fats in the blood. Fenofibrate belongs to a group of drugs known as "fibrates." Lowering triglycerides in people with very high triglyceride blood levels may decrease the risk of pancreas disease (pancreatitis). However, fenofibrate might not lower your risk of a heart attack or stroke. Talk to your doctor about the risks and benefits of fenofibrate. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.

In 2024, this provider wrote 20 Medicare prescriptions for Fenofibrate, about 76% of the volume of the typical Pennsylvania prescriber of this medication (26.2). Medicare paid an average of $62.33 per fill, versus $28.78 statewide.

How often this provider prescribes it

This provider
20
PA average
26.2

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$62.33
PA average
$28.78

Gross Part D cost per fill; not the patient's out-of-pocket price.

34
30-Day Fills
standardized to 30-day supplies
1,001
Days of Medication
total across all patients in 2024

About Novolog: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

In 2024, this provider wrote 20 Medicare prescriptions for Novolog, about 71% of the volume of the typical Pennsylvania prescriber of this medication (28.1). Medicare paid an average of $291.20 per fill, versus $253.94 statewide.

How often this provider prescribes it

This provider
20
PA average
28.1

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$291.20
PA average
$253.94

Gross Part D cost per fill; not the patient's out-of-pocket price.

37.8
30-Day Fills
standardized to 30-day supplies
1,135
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 19 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about 81% of the volume of the typical Pennsylvania prescriber of this medication (23.4). Medicare paid an average of $47.35 per fill, versus $79.79 statewide.

How often this provider prescribes it

This provider
19
PA average
23.4

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$47.35
PA average
$79.79

This provider's average cost per fill is below the PA average for this medication.

52
30-Day Fills
standardized to 30-day supplies
1,555
Days of Medication
total across all patients in 2024

About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

In 2024, this provider wrote 19 Medicare prescriptions for Glipizide, about half the volume of the typical Pennsylvania prescriber of this medication (34.4). Medicare paid an average of $11.37 per fill, versus $9.82 statewide.

How often this provider prescribes it

This provider
19
PA average
34.4

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$11.37
PA average
$9.82

Gross Part D cost per fill; not the patient's out-of-pocket price.

55
30-Day Fills
standardized to 30-day supplies
1,650
Days of Medication
total across all patients in 2024

About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾

It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

In 2024, this provider wrote 19 Medicare prescriptions for Atorvastatin Calcium, about 9% of the volume of the typical Pennsylvania prescriber of this medication (216.6). Medicare paid an average of $15.52 per fill, versus $12.25 statewide.

How often this provider prescribes it

This provider
19
PA average
216.6

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.52
PA average
$12.25

Gross Part D cost per fill; not the patient's out-of-pocket price.

57
30-Day Fills
standardized to 30-day supplies
1,710
Days of Medication
total across all patients in 2024

About Humulin R U-500 Kwikpen: Concentrated insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes who require large doses of insulin (more than 200 units per day). Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It works right away like regular insulin but its effects last longer. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication may be used alone or with other oral diabetes drugs (such as metformin). Regular insulin preparations that contain the HUMAN insulin peptide sequence.

In 2024, this provider wrote 18 Medicare prescriptions for Humulin R U-500 Kwikpen, about 66% of the volume of the typical Pennsylvania prescriber of this medication (27.1). Medicare paid an average of $1,762.17 per fill, versus $1,659.90 statewide.

How often this provider prescribes it

This provider
18
PA average
27.1

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,762.17
PA average
$1,659.90

Gross Part D cost per fill; not the patient's out-of-pocket price.

30.9
30-Day Fills
standardized to 30-day supplies
896
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 16 Medicare prescriptions for Pen Needle, about the same volume as the typical Pennsylvania prescriber of this medication (15.3). Medicare paid an average of $19.13 per fill, versus $29.15 statewide.

How often this provider prescribes it

This provider
16
PA average
15.3

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$19.13
PA average
$29.15

This provider's average cost per fill is below the PA average for this medication.

16.7
30-Day Fills
standardized to 30-day supplies
425
Days of Medication
total across all patients in 2024

About Xultophy 100-3.6: This medication is a combination of insulin degludec and liraglutide and is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Liraglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and decreasing the amount of sugar your liver makes.

In 2024, this provider wrote 15 Medicare prescriptions for Xultophy 100-3.6, about 63% of the volume of the typical Pennsylvania prescriber of this medication (23.9). Medicare paid an average of $2,659.94 per fill, versus $1,547.39 statewide.

How often this provider prescribes it

This provider
15
PA average
23.9

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,659.94
PA average
$1,547.39

Gross Part D cost per fill; not the patient's out-of-pocket price.

49
30-Day Fills
standardized to 30-day supplies
1,470
Days of Medication
total across all patients in 2024

About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a "water pill" (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)

In 2024, this provider wrote 15 Medicare prescriptions for Spironolactone, about a third of the volume of the typical Pennsylvania prescriber of this medication (47.5). Medicare paid an average of $15.62 per fill, versus $8.70 statewide.

How often this provider prescribes it

This provider
15
PA average
47.5

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.62
PA average
$8.70

Gross Part D cost per fill; not the patient's out-of-pocket price.

43
30-Day Fills
standardized to 30-day supplies
1,290
Days of Medication
total across all patients in 2024

About Synjardy Xr: This medication is a combination of 2 drugs: empagliflozin and metformin. Show more ▾

It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used to treat heart failure in people with type 2 diabetes. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines.

In 2024, this provider wrote 15 Medicare prescriptions for Synjardy Xr, about half the volume of the typical Pennsylvania prescriber of this medication (29.9). Medicare paid an average of $870.15 per fill, versus $942.49 statewide.

How often this provider prescribes it

This provider
15
PA average
29.9

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$870.15
PA average
$942.49

This provider's average cost per fill is below the PA average for this medication.

23
30-Day Fills
standardized to 30-day supplies
689
Days of Medication
total across all patients in 2024

About Testosterone: This medicated gel contains testosterone. Show more ▾

It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.

In 2024, this provider wrote 15 Medicare prescriptions for Testosterone, about 64% of the volume of the typical Pennsylvania prescriber of this medication (23.5). Medicare paid an average of $65.90 per fill, versus $145.89 statewide.

How often this provider prescribes it

This provider
15
PA average
23.5

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$65.90
PA average
$145.89

This provider's average cost per fill is below the PA average for this medication.

20.7
30-Day Fills
standardized to 30-day supplies
580
Days of Medication
total across all patients in 2024

About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn.

In 2024, this provider wrote 14 Medicare prescriptions for Basaglar Kwikpen U-100, about half the volume of the typical Pennsylvania prescriber of this medication (29.3). Medicare paid an average of $632.24 per fill, versus $359.72 statewide.

How often this provider prescribes it

This provider
14
PA average
29.3

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$632.24
PA average
$359.72

Gross Part D cost per fill; not the patient's out-of-pocket price.

38.4
30-Day Fills
standardized to 30-day supplies
1,146
Days of Medication
total across all patients in 2024

About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾

It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

In 2024, this provider wrote 14 Medicare prescriptions for Omeprazole, about 13% of the volume of the typical Pennsylvania prescriber of this medication (109.6). Medicare paid an average of $0.82 per fill, versus $12.24 statewide.

How often this provider prescribes it

This provider
14
PA average
109.6

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$0.82
PA average
$12.24

This provider's average cost per fill is below the PA average for this medication.

14
30-Day Fills
standardized to 30-day supplies
416
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 14 Medicare prescriptions for Easy Touch Pen Needle, about the same volume as the typical Pennsylvania prescriber of this medication (15.3). Medicare paid an average of $74.47 per fill, versus $47.74 statewide.

How often this provider prescribes it

This provider
14
PA average
15.3

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$74.47
PA average
$47.74

Gross Part D cost per fill; not the patient's out-of-pocket price.

20
30-Day Fills
standardized to 30-day supplies
533
Days of Medication
total across all patients in 2024

About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾

It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.

In 2024, this provider wrote 14 Medicare prescriptions for Tradjenta, about a third of the volume of the typical Pennsylvania prescriber of this medication (33.6). Medicare paid an average of $1,176.84 per fill, versus $654.10 statewide.

How often this provider prescribes it

This provider
14
PA average
33.6

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,176.84
PA average
$654.10

Gross Part D cost per fill; not the patient's out-of-pocket price.

34
30-Day Fills
standardized to 30-day supplies
1,020
Days of Medication
total across all patients in 2024

About Zoledronic Acid: This medication is used to treat a certain type of bone disease (Paget's disease) that causes abnormal and weak bones. Show more ▾

Zoledronic acid is also used to treat bone loss (osteoporosis) in men and in women after menopause who are at high risk of having broken bones (fractures). It may also be used to treat or prevent osteoporosis in people who are taking corticosteroid medications (such as prednisone) for long periods. It works by slowing the breakdown of bone and keeping bones strong. It also helps to reduce the risk of broken bones (fractures). This medication belongs to a class of drugs known as bisphosphonates. An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS.

In 2024, this provider wrote 13 Medicare prescriptions for Zoledronic Acid, about 65% of the volume of the typical Pennsylvania prescriber of this medication (20.1). Medicare paid an average of $189.18 per fill, versus $142.87 statewide.

How often this provider prescribes it

This provider
13
PA average
20.1

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$189.18
PA average
$142.87

Gross Part D cost per fill; not the patient's out-of-pocket price.

42
30-Day Fills
standardized to 30-day supplies
1,110
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 13 Medicare prescriptions for Droplet Pen Needle, about 64% of the volume of the typical Pennsylvania prescriber of this medication (20.3). Medicare paid an average of $105.22 per fill, versus $73.71 statewide.

How often this provider prescribes it

This provider
13
PA average
20.3

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$105.22
PA average
$73.71

Gross Part D cost per fill; not the patient's out-of-pocket price.

37.3
30-Day Fills
standardized to 30-day supplies
1,120
Days of Medication
total across all patients in 2024

About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT.

In 2024, this provider wrote 13 Medicare prescriptions for Rybelsus, about half the volume of the typical Pennsylvania prescriber of this medication (25). Medicare paid an average of $938.26 per fill, versus $1,332.80 statewide.

How often this provider prescribes it

This provider
13
PA average
25.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$938.26
PA average
$1,332.80

This provider's average cost per fill is below the PA average for this medication.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2024

About Repatha Sureclick: Evolocumab is used along with a proper diet to help lower "bad" cholesterol (LDL) in the blood. Show more ▾

It may be used with other LDL-lowering treatments (such as "statin" drugs, ezetimibe, LDL apheresis). Evolocumab is also used by people who have heart disease to reduce the risk of heart attack, stroke, and certain types of chest pain that require treatment in a hospital. This medication belongs to a class of drugs known as monoclonal antibodies. It works by improving how well your body gets rid of LDL cholesterol. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. Targets PCSK9.

In 2024, this provider wrote 12 Medicare prescriptions for Repatha Sureclick, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (47.9). Medicare paid an average of $581.01 per fill, versus $806.46 statewide.

How often this provider prescribes it

This provider
12
PA average
47.9

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$581.01
PA average
$806.46

This provider's average cost per fill is below the PA average for this medication.

12
30-Day Fills
standardized to 30-day supplies
352
Days of Medication
total across all patients in 2024

About Cabergoline: This medication is used to treat high levels of prolactin hormone in your body. Show more ▾

High levels of prolactin in women can cause symptoms such as unwanted breast milk and missed periods and can cause difficulty becoming pregnant. High levels of prolactin in men can cause symptoms such as enlarged breasts and decreased sexual ability/desire. Cabergoline is an ergot medication and works by blocking the release of prolactin from the pituitary gland. An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.

In 2024, this provider wrote 12 Medicare prescriptions for Cabergoline, about 62% of the volume of the typical Pennsylvania prescriber of this medication (19.4). Medicare paid an average of $89.86 per fill, versus $66.22 statewide.

How often this provider prescribes it

This provider
12
PA average
19.4

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$89.86
PA average
$66.22

Gross Part D cost per fill; not the patient's out-of-pocket price.

25
30-Day Fills
standardized to 30-day supplies
726
Days of Medication
total across all patients in 2024

About Amitriptyline Hcl: This medication is used to treat depression. Show more ▾

Amitriptyline belongs to a class of drugs known as tricyclic antidepressants. It works by helping to restore the balance of certain natural substances in the brain. Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.

In 2024, this provider wrote 12 Medicare prescriptions for Amitriptyline Hcl, about half the volume of the typical Pennsylvania prescriber of this medication (26.7). Medicare paid an average of $9.13 per fill, versus $13.48 statewide.

How often this provider prescribes it

This provider
12
PA average
26.7

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$9.13
PA average
$13.48

This provider's average cost per fill is below the PA average for this medication.

12
30-Day Fills
standardized to 30-day supplies
360
Days of Medication
total across all patients in 2024

About Lyumjev Kwikpen U-100: Insulin lispro-aabc is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro-aabc is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro-aabc starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro-aabc may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2024, this provider wrote 12 Medicare prescriptions for Lyumjev Kwikpen U-100, about half the volume of the typical Pennsylvania prescriber of this medication (20.3). Medicare paid an average of $2,035.32 per fill, versus $600.95 statewide.

How often this provider prescribes it

This provider
12
PA average
20.3

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,035.32
PA average
$600.95

Gross Part D cost per fill; not the patient's out-of-pocket price.

26.5
30-Day Fills
standardized to 30-day supplies
796
Days of Medication
total across all patients in 2024

About Humulin R U-500: Concentrated insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes who require large doses of insulin (more than 200 units per day). Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It works right away like regular insulin but its effects last longer. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication may be used alone or with other oral diabetes drugs (such as metformin). Regular insulin preparations that contain the HUMAN insulin peptide sequence.

In 2024, this provider wrote 12 Medicare prescriptions for Humulin R U-500, about 70% of the volume of the typical Pennsylvania prescriber of this medication (17.2). Medicare paid an average of $2,065.56 per fill, versus $2,214.28 statewide.

How often this provider prescribes it

This provider
12
PA average
17.2

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,065.56
PA average
$2,214.28

This provider's average cost per fill is below the PA average for this medication.

18.7
30-Day Fills
standardized to 30-day supplies
558
Days of Medication
total across all patients in 2024

About Calcitriol: Calcitriol is a man-made active form of vitamin D. Show more ▾

Most people get enough vitamin D from exposure to the sun and from fortified food products (such as dairy products, vitamins). Vitamin D helps control parathyroid hormone and the levels of certain minerals (such as calcium, phosphorus) that are needed for building and keeping strong bones. Before regular vitamin D can be used by the body, it needs to be changed to the active form by the liver and kidneys. Calcitriol is used in patients with kidney disease who can't make enough of the active form of Vitamin D. This medication is also used to prevent and treat certain types of calcium/phosphorus/parathyroid problems that can happen with long-term kidney dialysis or hypoparathyroidism. Calcitriol is usually used along with specific diet recommendations and sometimes other medications. The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.

In 2024, this provider wrote 12 Medicare prescriptions for Calcitriol, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (48.2). Medicare paid an average of $39.80 per fill, versus $16.44 statewide.

How often this provider prescribes it

This provider
12
PA average
48.2

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$39.80
PA average
$16.44

Gross Part D cost per fill; not the patient's out-of-pocket price.

31
30-Day Fills
standardized to 30-day supplies
905
Days of Medication
total across all patients in 2024

About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾

It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

In 2024, this provider wrote 11 Medicare prescriptions for Losartan Potassium, about 10% of the volume of the typical Pennsylvania prescriber of this medication (112.8). Medicare paid an average of $13.60 per fill, versus $11.18 statewide.

How often this provider prescribes it

This provider
11
PA average
112.8

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$13.60
PA average
$11.18

Gross Part D cost per fill; not the patient's out-of-pocket price.

23
30-Day Fills
standardized to 30-day supplies
690
Days of Medication
total across all patients in 2024

About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2024, this provider wrote 11 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about a third of the volume of the typical Pennsylvania prescriber of this medication (28.6). Medicare paid an average of $207.60 per fill, versus $156.40 statewide.

How often this provider prescribes it

This provider
11
PA average
28.6

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$207.60
PA average
$156.40

Gross Part D cost per fill; not the patient's out-of-pocket price.

17.7
30-Day Fills
standardized to 30-day supplies
482
Days of Medication
total across all patients in 2024

About Desmopressin Acetate: Desmopressin is used to control the amount of urine your kidneys make. Show more ▾

Normally, the amount of urine you make is controlled by a certain substance in the body called vasopressin. In people who have "water diabetes" (diabetes insipidus) or certain kinds of head injury or brain surgery, the body does not make enough vasopressin. Desmopressin is a man-made form of vasopressin and is used to replace a low level of vasopressin. This medication helps to control increased thirst and too much urination due to these conditions, and helps prevent dehydration. Desmopressin is also used to control nighttime bedwetting in children. It reduces how often your child urinates and decreases the number of bedwetting episodes. A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.

In 2024, this provider wrote 11 Medicare prescriptions for Desmopressin Acetate, about half the volume of the typical Pennsylvania prescriber of this medication (19.5). Medicare paid an average of $87.52 per fill, versus $71.42 statewide.

How often this provider prescribes it

This provider
11
PA average
19.5

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$87.52
PA average
$71.42

Gross Part D cost per fill; not the patient's out-of-pocket price.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2024
No medications match the current filters.
= the 5 medications this provider prescribes most.▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average PA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the PA average cost per fill.

About this data. The prescription history for DR. LUCAS HELLER M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Endocrinology, Diabetes & Metabolism prescribing approach at this Irwin, PA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among PA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.